For help on how to get the results you want, see our search tips.
105 results
Categories
Human Remove Human filter
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
-
List item
Referral: Ciprofloxacin Bayer
ciprofloxacin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 07/10/2008, Last updated: 23/10/2008 -
List item
Referral: Seroquel XR
quetiapine, Article 6(13) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 22/04/2010, EC decision date: 26/08/2010, Last updated: 19/11/2010 -
List item
Referral: Sandimmun Neoral and associated names
ciclosporin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 27/06/2013, EC decision date: 31/10/2013, Last updated: 20/12/2013 -
List item
Referral: Stamaril
live attenuated yellow fever virus, Article 30 referrals
Status: European Commission final decision, opinion/position date: 27/04/2006, EC decision date: 04/07/2006, Last updated: 14/07/2006 -
List item
Referral: Atacand
candesartan, associated names: Amias, Blopress, Kenzen, Racanda, Ratacand, Parapres, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 13/07/2010, Last updated: 16/03/2011 -
List item
Referral: Zocord
simvastatin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/01/2004, EC decision date: 28/04/2004, Last updated: 09/06/2004 -
List item
Referral: Tienam
imipenem, cilastatin, associated names: Conet, Imipem, Primaxin, Tenacid, Zienam, Article 30 referrals
Status: European Commission final decision, opinion/position date: 16/12/2010, EC decision date: 10/03/2011, Last updated: 20/02/2012 -
List item
Referral: Diflucan
fluconazole, associated names: Fluconazole, Fungustatin, Fungata, Triflucan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 02/09/2011, Last updated: 02/02/2012 -
List item
Referral: Topamax
topiramate, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/06/2009, EC decision date: 01/10/2009, Last updated: 15/12/2009 -
List item
Referral: Vascace Plus
cilazapril, hydrochlorothiazide, associated names: Co-Inhibace, Dynorm Plus, Inhibace Plus, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/10/2010, EC decision date: 21/01/2011, Last updated: 09/11/2011 -
List item
Referral: Famvir
famciclovir, associated names: Famciclovir-Sandoz, Famciclovir-SB, Famciclovir-SB Zoster, Famvir Zoster and Oravir, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/04/2010, EC decision date: 27/07/2010, Last updated: 09/09/2011 -
List item
Referral: Cozaar
losartan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/04/2008, EC decision date: 03/09/2008, Last updated: 25/09/2008 -
List item
Referral: Risperdal Consta
risperidone, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 07/10/2008, Last updated: 22/10/2008 -
List item
Referral: Septanest and associated names
articaine (hydrochloride), adrenaline (tartrate), Article 30 referrals
Status: European Commission final decision, opinion/position date: 28/06/2018, EC decision date: 28/03/2019, Last updated: 19/06/2019 -
List item
Referral: Zinnat
cefuroxime axetil, associated names: Cefuroxima Solasma, Cefuroxima Allen, Cefuroxima Duncan, Elobact, Nivador, Oraxim, Selan, Tilexim, Zinadol, Zipos, Zoref, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/05/2012, EC decision date: 23/08/2012, Last updated: 29/01/2013 -
List item
Referral: Fortum
ceftazidime, associated names: Cefortam, Glazidim, Panzim, Solvetan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/10/2010, EC decision date: 13/01/2011, Last updated: 22/10/2010 -
List item
Referral: Seretide Evohaler
salmeterol, fluticasone, Article 6(13) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 27/04/2006, EC decision date: 04/07/2006, Last updated: 14/07/2007 -
List item
Referral: Protium
pantoprazole, associated names: Anagastra, Apton, Controloc, Eupantol, Inipomp, Pantec, Pantecta, Pantipp, Panto-Byk-20 / 40 / IV, Pantoc, Pantoloc, PantoLomberg, Pantopan, Pantorc, Pantozol, Peptazol, Rifun, Somac, Ulcotenal, Zurcal, Zurcale, Zurcazol, Article 30 referrals
Status: European Commission final decision, opinion/position date: 17/12/2009, EC decision date: 15/04/2010, Last updated: 17/01/2012 -
List item
Referral: Cozaar Comp
Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/04/2008, EC decision date: 03/09/2008, Last updated: 25/09/2008 -
List item
Referral: Augmentin
amoxicillin, clavulanic acid, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/01/2009, EC decision date: 19/10/2009, Last updated: 18/11/2013 -
List item
Referral: Rocephin
Ceftriaxone, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/01/2014, EC decision date: 21/03/2014, Last updated: 19/05/2014 -
List item
Referral: Diovan
valsartan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/11/2008, EC decision date: 16/02/2009, Last updated: 13/03/2009 -
List item
Referral: Calcium Sandoz
Calcium lactate gluconate, Calcium carbonate, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/04/2005, EC decision date: 09/08/2005, Last updated: 09/08/2005 -
List item
Referral: Motilium
domperidone, Article 30 referrals
Status: European Commission final decision, opinion/position date: 27/06/2002, EC decision date: 17/10/2002, Last updated: 17/10/2002 -
List item
Referral: Zyrtec
cetirizine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 30/05/2008, EC decision date: 06/10/2008, Last updated: 16/10/2008